These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


145 related items for PubMed ID: 37675618

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Therapeutic protein-polymer conjugates: advancing beyond PEGylation.
    Pelegri-O'Day EM, Lin EW, Maynard HD.
    J Am Chem Soc; 2014 Oct 15; 136(41):14323-32. PubMed ID: 25216406
    [Abstract] [Full Text] [Related]

  • 4. Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation.
    Zhang P, Sun F, Liu S, Jiang S.
    J Control Release; 2016 Dec 28; 244(Pt B):184-193. PubMed ID: 27369864
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Revealing the Immunogenic Risk of Polymers.
    Li B, Yuan Z, Hung HC, Ma J, Jain P, Tsao C, Xie J, Zhang P, Lin X, Wu K, Jiang S.
    Angew Chem Int Ed Engl; 2018 Oct 15; 57(42):13873-13876. PubMed ID: 30156051
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A double antigen bridging immunogenicity ELISA for the detection of antibodies to polyethylene glycol polymers.
    Liu Y, Reidler H, Pan J, Milunic D, Qin D, Chen D, Vallejo YR, Yin R.
    J Pharmacol Toxicol Methods; 2011 Oct 15; 64(3):238-45. PubMed ID: 21827863
    [Abstract] [Full Text] [Related]

  • 9. Antibodies against polyethylene glycol in human blood: A literature review.
    Hong L, Wang Z, Wei X, Shi J, Li C.
    J Pharmacol Toxicol Methods; 2020 Oct 15; 102():106678. PubMed ID: 31981619
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The impact of PEGylation on biological therapies.
    Veronese FM, Mero A.
    BioDrugs; 2008 Oct 15; 22(5):315-29. PubMed ID: 18778113
    [Abstract] [Full Text] [Related]

  • 12. Poly(Oxanorbornene)-Protein Conjugates Prepared by Grafting-to ROMP as Alternatives for PEG.
    Davis E, Caparco AA, Steinmetz NF, Pokorski JK.
    Macromol Biosci; 2024 Feb 15; 24(2):e2300255. PubMed ID: 37688508
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Conjugation of staphylokinase with the arabinogalactan-PEG conjugate: Study on the immunogenicity, in vitro bioactivity and pharmacokinetics.
    Qi F, Qi J, Hu C, Shen L, Yu W, Hu T.
    Int J Biol Macromol; 2019 Jun 15; 131():896-904. PubMed ID: 30914374
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Polypeptides as alternatives to PEGylation of therapeutic agents.
    Chen H, Zhang Q.
    Expert Opin Drug Deliv; 2024 Jun 15; 21(1):1-12. PubMed ID: 38116624
    [Abstract] [Full Text] [Related]

  • 17. PEGylation within a confined hydrophobic cavity of a protein.
    Munasinghe A, Mathavan A, Mathavan A, Lin P, Colina CM.
    Phys Chem Chem Phys; 2019 Nov 27; 21(46):25584-25596. PubMed ID: 31720639
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. One to one comparison of cell-free synthesized erythropoietin conjugates modified with linear polyglycerol and polyethylene glycol.
    Pouyan P, Zemella A, Schloßhauer JL, Walter RM, Haag R, Kubick S.
    Sci Rep; 2023 Apr 19; 13(1):6394. PubMed ID: 37076514
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.